[1]
“Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders”, AJPS, vol. 25, no. 5, pp. 917–930, Jan. 2026, doi: 10.32947/ajps.v25i5.1307.